24514 Federal Register / Vol. 61, No. 95 / Wednesday, May 15, 1996 / Notices

Advanced Micro Devices, Inc., Austin,

TX.

APCFIP’s area of planned activity is

development of advanced process

control required by the semiconductor

manufacturing industry.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12110 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Consortium for Integrated

Intelligent Manufacturing, Planning

and Execution

Notice is hereby given that, on April

24, 1996, pursuant to § 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Consortium for

Integrated Intelligent Manufacturing,

Planning and Execution (‘‘CIIMPLEX’’)

has filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specific

circumstances. Pursuant to § 6(b) of the

Act, the identities of the parties are:

International Business Machines

(‘‘IBM’’) Corporation, Charlotte, NC;

Berclain U.S.A., Schaumberg, IL;

Ingersoll Rand, Woodcliff Lake, NJ; J.D.

Edwards, Denver, CO; and QUD Inc.,

Mt. Laurel, NJ.

The CIIMPLEX Consortium’s area of

planned activity is the development of

open industry software protocols that

will integrate manufacturing, planning

and execution computing environments

across the U.S. manufacturing base.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12108 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—the Frame Relay Forum

Notice is hereby given that, on April

29, 1996, pursuant to § 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the Frame Relay

Forum (‘‘Forum’’), has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of invoking the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the changes are as follows:

Cellstream Networks, Inc., Sarasota, FL;

Comsat Corporation, Clarksburg, MD;

Digital Equipment Corporation, Berks,

UNITED KINGDOM; Hekemian

Laboratories, Inc., Rockville, MD; and

InComA, Ltd, Moscow RUSSIA; have

been added as members to the venture.

Nortel DASA, Friedrichs Hafem,

GERMANY has been added as an

affiliate member. Loral Data Systems,

Sarasota, FL; and Defense Research

Agency, Malvern, Worcestershire,

UNITED KINGDOM have been dropped

as members of the venture.

On April 10, 1992, the Forum filed its

original notification pursuant to § 6(b) of

the Act. The Department of Justice

published a notice in the Federal

Register pursuant to § 6(b) of the Act on

July 2, 1992 (57 FR 29537). The last

notification was filed on December 27,

1995. A notice was published in the

Federal Register on February 20, 1996

(61 FR 6389).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12109 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; the ATM Forum

Notice is hereby given that, on

February 2, 1996, pursuant to § 6(a) of

the National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), the ATM Forum

(‘‘Forum’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership. The notifications were

filed for the purpose of extending the

Act’s provisions limiting the recovery of

antitrust plaintiffs to actual damages

under specified circumstances.

Specifically, the changes are as follows:

ABB, HAFO, Jarfalla, SWEDEN; Anixter,

Inc., Skokie, IL; Anritsu Wiltron, AtsugiShi, Kanagawa, JAPAN; Belgacom,

Brussels, BELGIUM; Diamond Lane

Communications, Petaluma, CA; GN

Nettest, Markham, Ontario, CANADA;

Incite, Dallas, TX; Integrated Systems

Technology, Lanham, MD; LittonFibercom, Roanoke, VA; Molex, Lisle,

IL; Scope Communications, Northboro,

MA; Southern New England Telephone,

North Haven, CT; Super Highway

Company, New York, NY; US Robotics,

Westborough, MA; and Wandel &

Goltermann, Eningen, GERMANY have

been added to the venture. Telenex has

changed its name to General Signal

Networks. Chipcom has withdrawn

from the venture.

On April 19, 1993, the Forum filed its

original notification pursuant to section

6(b) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant section 6(b) of the Act

on June 2, 1993 (58 FR 45532). The last

notification was filed on August 8, 1995.

A notice was published in the Federal

Register on March 12, 1996 (61 FR

10011).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 96–12107 Filed 5–14–96; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated February 2, 1996, and

published in the Federal Register on

February 13, 1996, (61 FR 5570), Isotec

Inc., 3858 Benner Road, Miamisburg,

Ohio 45342, made application to the

Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) ........................ I

Methcathinone (1237) ................. I

N-Ethylamphetamine (1475) ....... I

N,N-Dimethylamphetamine

(1480) ...................................... I

Aminorex (1585) ......................... I

Methaqualone (2565) .................. I

Lysergic acid diethylamide

(7315) ...................................... I

Tetrahydrocannabinols (7370) .... I

Mescaline (7381) ........................ I

2,5-Dimethoxyamphetamine

(7396) ...................................... I

3,4-Methylenedioxyamphetamine

(7400) ...................................... I

3,4-Methylenedioxy-Nethylamphetamine (7404) ....... I

3,4-Methylenedioxymethamphetamine (7405) .................... I

Psilocybin (7437) ........................ I

Psilocyn (7438) ........................... I

N-Ethyl-1-phenylcyclohexylamine

(7455) ...................................... I

Dihydromorphine (9145) ............. I

Normorphine (9313) .................... I

Acetylmethadol (9601) ................ I

Alphacetylmethadol Except

Levo-Alphacetylmethadol

(9603) ...................................... I

Normethadone (9635) ................. I

3-Methylfentanyl (9813) .............. I